Detail Information of Genetic Polymorphisms
| General Information of Drug Transporter (DT) | |||||
|---|---|---|---|---|---|
| DT ID | DTD0151 Transporter Info | ||||
| Gene Name | SLC22A4 | ||||
| Protein Name | Organic cation/carnitine transporter 1 | ||||
| Gene ID | |||||
| UniProt ID | |||||
| Genetic Polymorphisms of DT (GPD) | |||||
| Genetic Polymorphism | rs1050152 | ||||
| Site of GPD | chr5:132340627 (GRCh38.p12) | ||||
| GPD Type | SNP | ||||
| Allele(s) in dbSNP | C>T | ||||
| Minor Allele Frequency | T=0.1344/673 (Global) | ||||
| Genotype TT | Click to Show/Hide the Full List of Affected Drugs: 2 Drugs in Total | ||||
| Imatinib | Drug Info | Gastrointestinal Stromal Tumors | Correlated with the decreased drug response in patients (compare with genotypes CC + CT) | [ 1] | |
| Imatinib | Drug Info | Bcr-Abl Positive Chronic Myelogenous Leukemia | Correlated with the decreased drug response in patients (compare with genotypes CC + CT); Irrelevant to the drug response in patients (compare with genotypes CC + CT) | [ 2] | |
| References | |||||
| 1 | Polymorphisms in OCTN1 and OCTN2 transporters genes are associated with prolonged time to progression in unresectable gastrointestinal stromal tumours treated with imatinib therapy. Pharmacol Res. 2013 Feb;68(1):1-6. | ||||
| 2 | Association between imatinib transporters and metabolizing enzymes genotype and response in newly diagnosed chronic myeloid leukemia patients receiving imatinib therapy. Haematologica. 2013 Feb;98(2):193-200. | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.